Jubilant Life Sciences launches generic version of remdesivir for COVID-19 treatment

In order to increase accessibility of the drug to patients below the poverty line and to front-line paramedical staff, Jubilant Bhartia Foundation, a not-for-profit organisation of the Jubilant Group, is launching programs in India aimed at its distribution, it added.

from Moneycontrol Business News https://ift.tt/3foknSk